Correction to: Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinoma
Guardado en:
Autores principales: | Ao Zhang, Guanqing Zhong, Luocan Wang, Rongzeng Cai, Runkun Han, Caixia Xu, Shulin Chen, Peng Sun, Hao Chen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a87da5c5bc344ab79df170416cef424e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
USP5 facilitates non-small cell lung cancer progression through stabilization of PD-L1
por: Jinghua Pan, et al.
Publicado: (2021) -
System Analysis of ROS-Related Genes in the Prognosis, Immune Infiltration, and Drug Sensitivity in Hepatocellular Carcinoma
por: Jun Hui Xu, et al.
Publicado: (2021) -
ONECUT2 facilitates hepatocellular carcinoma metastasis by transcriptionally upregulating FGF2 and ACLY
por: Danfei Liu, et al.
Publicado: (2021) -
Spatial transcriptomics reveals gene expression characteristics in invasive micropapillary carcinoma of the breast
por: Jianke Lv, et al.
Publicado: (2021) -
Correction to: RNA-binding protein SORBS2 suppresses clear cell renal cell carcinoma metastasis by enhancing MTUS1 mRNA stability
por: Qi Lv, et al.
Publicado: (2021)